[HTML][HTML] A Clinical Guide to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Neuroendocrine Tumor Patients
MN Becx, NS Minczeles, T Brabander, WW de Herder… - Cancers, 2022 - mdpi.com
Simple Summary Peptide receptor radionuclide therapy (PRRT) is one of the treatment
options for locally advanced or metastatic gastroenteropancreatic (GEP) neuroendocrine …
options for locally advanced or metastatic gastroenteropancreatic (GEP) neuroendocrine …
[HTML][HTML] A review of advances in the last decade on targeted cancer therapy using 177Lu: Focusing on 177Lu produced by the direct neutron activation route
R Chakravarty, S Chakraborty - American Journal of Nuclear …, 2021 - ncbi.nlm.nih.gov
Abstract Lutetium-177 [T½= 6.76 d; E β (max)= 0.497 MeV; maximum tissue range~ 2.5 mm;
208 keV γ-ray] is one of the most important theranostic radioisotope used for the …
208 keV γ-ray] is one of the most important theranostic radioisotope used for the …
[HTML][HTML] One decade of 'bench-to-bedside'peptide receptor radionuclide therapy with indigenous [177Lu] Lu-DOTATATE obtained through 'direct'neutron activation …
S Basu, S Chakraborty, RV Parghane… - American Journal of …, 2020 - ncbi.nlm.nih.gov
The present treatise chronicles one decade of experience pertaining to clinical PRRT
services in a large-volume tertiary cancer care centre in India delivering over 4,000 …
services in a large-volume tertiary cancer care centre in India delivering over 4,000 …
Peptide receptor radionuclide therapy in neuroendocrine neoplasms and related tumors: from fundamentals to personalization and the newer experimental …
S Loharkar, S Basu - Expert Review of Precision Medicine and …, 2023 - Taylor & Francis
ABSTRACT Introduction Peptide Receptor Radionuclide Therapy (PRRT) is a type of
molecular-targeted endo-radionuclide therapy in which unsealed radiolabelled somatostatin …
molecular-targeted endo-radionuclide therapy in which unsealed radiolabelled somatostatin …
Timing of peptide receptor radiotargeted therapy in relation to cardiac valve surgery for carcinoid heart disease in patients with neuroendocrine metastases and …
LM Davis, N Nicou, W Martin, B Corcoran… - Nuclear Medicine …, 2020 - journals.lww.com
Method Retrospective case notes review was performed on 18 neuroendocrine neoplasm
patients (mean 60 years), who underwent heart valve surgery between 2003 and 2017 for …
patients (mean 60 years), who underwent heart valve surgery between 2003 and 2017 for …